---
schema_version: "secwatch.filing_event.v1"
accession: "0000200406-23-000115"
form_type: "8-K"
ticker: "JNJ"
cik: "0000200406"
company_name: "JOHNSON & JOHNSON"
filed_at: "2023-12-05T23:59:59+00:00"
generated_at: "2026-06-07T18:19:43.672191+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Eugene A. Woods elected to Johnson & Johnson Board of Directors

## Summary
- Eugene A. Woods, CEO of Advocate Health, joined the board as a non-employee director effective Nov 30, 2023.
- Mr. Woods will receive standard non-employee director compensation as described in 2023 Proxy Statement.
- Advocate Health purchased ~$175M of Johnson & Johnson products in FY2022; JNJ paid <$1M for clinical trials.

## SEC filing metadata
- accession: 0000200406-23-000115
- form_type: 8-K
- ticker: JNJ
- cik: 0000200406
- company_name: JOHNSON & JOHNSON
- filed_at: 2023-12-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/200406/000020040623000115/0000200406-23-000115-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/200406/000020040623000115/jnj-20231130.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000200406-23-000115
- JSON: https://secwatch.observer/filing/0000200406-23-000115.json
- Plain text: https://secwatch.observer/filing/0000200406-23-000115.txt

## Key facts
- Executive change
  Eugene A. Woods was elected as Director at JOHNSON & JOHNSON.
  - Action: elected
  - Role: Director
  source text: On November 30, 2023, Johnson & Johnson (the “Company” or “Johnson & Johnson”) announced that Eugene A. Woods, MBA, MHA, was elected to the Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/200406/000020040623000115/0000200406-23-000115-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.